These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3611312)

  • 61. Results from a Prospective
    Fuchs F; Hamprecht A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.
    Haller I
    Arzneimittelforschung; 1986 Feb; 36(2):226-9. PubMed ID: 2938593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 67. Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.
    Banic S
    APMIS; 2006 Jan; 114(1):3-9. PubMed ID: 16499654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
    Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
    Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillin.
    Sanders CC; Sanders WE; Goering RV; McCloskey RV
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1164-8. PubMed ID: 3498436
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.
    Neu HC
    Pharmacotherapy; 1985; 5(1):1-10. PubMed ID: 3885172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Dec; 24(6):1055-9. PubMed ID: 3097064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019
    Humphries RM; Hindler JA; Shaffer K; Campeau SA
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567744
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparative evaluation of the Enterobacteriaceae sensitivity to 6-(N,N-1', 6-hexyleneformamidino)-penicillanic acid and ampicillin].
    Zaremba M; Kacprzak-Wiatr A; Zukowska-Nytko K; Bortnik-Kozikowska B; Piotrowski J; Borowski J
    Pol Tyg Lek; 1979 May; 34(22):861-4. PubMed ID: 225732
    [No Abstract]   [Full Text] [Related]  

  • 76. Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method.
    Smith KP; Brennan-Krohn T; Weir S; Kirby JE
    J Clin Microbiol; 2017 Feb; 55(2):470-478. PubMed ID: 27903600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Afridi FI; Farooqi BJ
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):358-62. PubMed ID: 22630093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):378-81. PubMed ID: 6508266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.